Publicaciones en las que colabora con Francisco Javier Gil Bea (31)

2021

  1. Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus

    PLoS ONE, Vol. 16, Núm. 2 February

2018

  1. Adrenomedullin, a Novel Target for Neurodegenerative Diseases

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8799-8814

  2. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

  3. Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 9328-9333

2017

  1. Adrenomedullin contributes to age-related memory loss in mice and is elevated in aging human brains

    Frontiers in Molecular Neuroscience, Vol. 10

  2. Aggregation of the inflammatory s100a8 precedes a? plaque formation in transgenic app mice: Positive feedback for s100a8 and a? productions

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 72, Núm. 3, pp. 319-328

  3. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2016

  1. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

    Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

  2. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482

2013

  1. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 6, pp. 837-847

  2. Mineralocorticoid Receptor Activation Induces Insulin Resistance Through c-Jun N-terminal kinases in Response to Chronic Corticosterone: Cognitive Implications

    Journal of Neuroendocrinology, Vol. 25, Núm. 4, pp. 350-356

2012

  1. Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice

    Neurobiology of Disease, Vol. 48, Núm. 3, pp. 439-446

  2. Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and Arc levels and impairs memory in young mice

    Journal of Alzheimer's Disease, Vol. 32, Núm. 2, pp. 341-355

2011

  1. Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF down regulation

    Hippocampus, Vol. 21, Núm. 9, pp. 999-1009

2010

  1. Altered NCAM expression associated with the cholinergic system in alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 20, Núm. 2, pp. 659-668

  2. HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 829-838

  3. Insulin levels are decreased in the cerebrospinal fluid of women with prodomal alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 2, pp. 405-413

2009

  1. Effects of chronic blockade of 5-HT6 receptors on NMDA receptor subunits expression

    Synapse, Vol. 63, Núm. 9, pp. 814-816

  2. Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: Involvement of the HPA axis

    Psychoneuroendocrinology, Vol. 34, Núm. 10, pp. 1495-1505